Tesla’s (NASDAQ:TSLA) CEO, Elon Musk, stated in a Spaces session on social media platform X that a patient implanted with Neuralink’s brain technology can control a computer mouse with thoughts. Neuralink is a company owned by Musk that has developed a brain implant that can help humans use neural signals to control external technologies.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Elaborating further, Musk commented that the patient has made a full recovery with no ill effects so far and is able to control the movements of a computer mouse just by thinking. The startup initiated its first human clinical trial in January following approval from the U.S. Food and Drug Administration (FDA) in May. Neuralink uses a robot to implant the device in the brain.
The in-human clinical trial, if successful, would mean that Neuralink is just one step away from its path toward commercialization.
What Is the Tesla Stock Price Prediction?
When it comes to Tesla, analysts remain sidelined about the stock with a Hold consensus rating based on 12 Buys, 17 Holds, and five Sells. Year-to-date, TSLA has slid by more than 15%, and the average TSLA price target of $218.75 implies an upside potential of 9.4% at current levels.
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue